Inactive Instrument
Probi AB Share Price
Stocks
PROB
SE0001280355
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 07/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 31/07/2025 |
James Henson
COO | Chief Operating Officer | 39 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 31/12/2013 |
| Chairman | 62 | 31/03/2015 | |
| Director/Board Member | 64 | 03/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/02/25 | Buy | Company | 142,586 | 1.2514% | ||
| 21/01/25 | Buy | Company | 2,840,101 | 24.9260% | ||
| 28/11/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.29% | - | - | 33.68M | |
| +1.04% | +2.34% | +54.91% | +111.75% | 1,038B | |
| -0.19% | +1.18% | +52.94% | +66.69% | 649B | |
| +0.20% | +1.04% | +18.88% | +72.38% | 467B | |
| -0.81% | +0.58% | +33.79% | +45.43% | 355B | |
| -0.05% | +2.04% | +18.17% | +26.34% | 269B | |
| +0.38% | +4.08% | +9.65% | +14.16% | 260B | |
| +1.95% | +3.06% | +37.75% | +45.93% | 213B | |
| -1.26% | -6.72% | -32.84% | -59.88% | 176B | |
| +0.30% | +2.83% | +31.97% | +100.03% | 187B | |
| Average | +0.26% | +1.04% | +25.02% | +46.98% | 401.68B | |
| Weighted average by Cap. | +0.54% | +1.47% | +35.35% | +65.82% |
Employees
-
Sector
Pharmaceuticals
